{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:14:06Z","timestamp":1793783646368,"version":"4.6.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001688","name":"International Centre for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.omtm.2023.101161","type":"journal-article","created":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T17:35:00Z","timestamp":1700415300000},"page":"101161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["CRISPR-Cas9-mediated somatic correction of a one-base deletion in the Ugt1a gene ameliorates hyperbilirubinemia in Crigler-Najjar syndrome mice"],"prefix":"10.1016","volume":"31","author":[{"given":"Giulia","family":"Bortolussi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Iaconcig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Canarutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Porro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Galletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"D\u00edaz-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipin","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"De Caneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olayemi Joseph","family":"Olajide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Zentilin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvano","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luka","family":"Bo\u010dkor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9628-0494","authenticated-orcid":false,"given":"Andr\u00e9s Fernando","family":"Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2023.101161_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/21678707.2018.1495558","article-title":"Advances in understanding disease mechanisms and potential treatments for Crigler\u2013Najjar syndrome","volume":"6","author":"Bortolussi","year":"2018","journal-title":"Expert Opinion on Orphan Drugs"},{"key":"10.1016\/j.omtm.2023.101161_bib2","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1016\/S0021-9258(17)32403-1","article-title":"Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man","volume":"269","author":"Bosma","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2023.101161_bib3","first-page":"169","article-title":"Congenital familial nonhemolytic jaundice with kernicterus","volume":"10","author":"Crigler","year":"1952","journal-title":"Pediatrics"},{"key":"10.1016\/j.omtm.2023.101161_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.510240205","article-title":"Current therapy for Crigler-Najjar syndrome type 1: report of a world registry","volume":"24","author":"van der Veere","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.omtm.2023.101161_bib5","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMra1308124","article-title":"Bilirubin-induced neurologic damage--mechanisms and management approaches","volume":"369","author":"Watchko","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2023.101161_bib6","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1056\/NEJMct0708376","article-title":"Phototherapy for neonatal jaundice","volume":"358","author":"Maisels","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2023.101161_bib7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jhep.2013.04.004","article-title":"Monogenic diseases that can be cured by liver transplantation","volume":"59","author":"Fagiuoli","year":"2013","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.omtm.2023.101161_bib8","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)","volume":"57","author":"Adam","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.omtm.2023.101161_bib9","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.ymthe.2020.06.001","article-title":"Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B","volume":"28","author":"George","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.101161_bib10","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1056\/NEJMoa1708538","article-title":"Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant","volume":"377","author":"George","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2023.101161_bib11","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa1407309","article-title":"Long-term safety and efficacy of factor IX gene therapy in hemophilia B","volume":"371","author":"Nathwani","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2023.101161_bib12","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/mt.2010.274","article-title":"Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins","volume":"19","author":"Nathwani","year":"2011","journal-title":"Mol. Ther. : the journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.omtm.2023.101161_bib13","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1708483","article-title":"AAV5-Factor VIII Gene Transfer in Severe Hemophilia A","volume":"377","author":"Rangarajan","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2023.101161_bib14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.1142658","article-title":"AAV vector integration sites in mouse hepatocellular carcinoma","volume":"317","author":"Donsante","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.omtm.2023.101161_bib15","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/sj.gt.3301541","article-title":"Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors","volume":"8","author":"Donsante","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2023.101161_bib16","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1089\/hum.2013.233","article-title":"Life-long correction of hyperbilirubinemia with a neonatal liver-specific AAV-mediated gene transfer in a lethal mouse model of Crigler-Najjar Syndrome","volume":"25","author":"Bortolussi","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2023.101161_bib17","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/mt.2008.72","article-title":"Gene delivery to the juvenile mouse liver using AAV2\/8 vectors","volume":"16","author":"Cunningham","year":"2008","journal-title":"Mol. Ther. : the journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.omtm.2023.101161_bib18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/hum.2011.183","article-title":"Hepatic gene transfer in neonatal mice by adeno-associated virus serotype 8 vector","volume":"23","author":"Wang","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2023.101161_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 In\u00a0Vivo Gene Editing for Transthyretin Amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2023.101161_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 Gene Editing for Sickle Cell Disease and \u03b2-Thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2023.101161_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4254\/wjh.v10.i2.277","article-title":"Homologous recombination mediates stable Fah gene integration and phenotypic correction in tyrosinaemia mouse-model","volume":"10","author":"Junge","year":"2018","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.omtm.2023.101161_bib22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nbt.2884","article-title":"Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype","volume":"32","author":"Yin","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2023.101161_bib23","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/hep.31570","article-title":"Promoterless, Nuclease-Free Genome Editing Confers a Growth Advantage for Corrected Hepatocytes in Mice With Methylmalonic Acidemia","volume":"73","author":"Chandler","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.omtm.2023.101161_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2022.06.011","article-title":"Growth advantage of corrected hepatocytes in a juvenile model of methylmalonic acidemia following liver directed adeno-associated viral mediated nuclease-free genome editing","volume":"137","author":"Venturoni","year":"2022","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omtm.2023.101161_bib25","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM200106073442307","article-title":"The Hemophilias \u2014 From Royal Genes to Gene Therapy","volume":"344","author":"Mannucci","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2023.101161_bib26","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1182\/blood-2013-04-497354","article-title":"Robust ZFN-mediated genome editing in adult hemophilic mice","volume":"122","author":"Anguela","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2023.101161_bib27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature13864","article-title":"Promoterless gene targeting without nucleases ameliorates haemophilia B in mice","volume":"517","author":"Barzel","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2023.101161_bib28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature10177","article-title":"In\u00a0vivo genome editing restores haemostasis in a mouse model of haemophilia","volume":"475","author":"Li","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2023.101161_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2022.785698","article-title":"Promoterless Gene Targeting Approach Combined to CRISPR\/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal Mice","volume":"4","author":"Lisjak","year":"2022","journal-title":"Frontiers in Genome Editing"},{"key":"10.1016\/j.omtm.2023.101161_bib30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.15252\/emmm.201506039","article-title":"CRISPR\/Cas9-mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse","volume":"8","author":"Guan","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtm.2023.101161_bib31","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.omtm.2020.06.025","article-title":"CRISPR-Cas9-Mediated In\u00a0Vivo Gene Integration at the Albumin Locus Recovers Hemostasis in Neonatal and Adult Hemophilia B Mice","volume":"18","author":"Wang","year":"2020","journal-title":"Molecular Therapy - Methods\u00a0& Clinical Development"},{"key":"10.1016\/j.omtm.2023.101161_bib32","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1182\/blood-2014-12-615492","article-title":"In\u00a0vivo genome editing of the albumin locus as a platform for protein replacement therapy","volume":"126","author":"Sharma","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2023.101161_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.128863","article-title":"Coupling AAV-mediated promoterless gene targeting to SaCas9 nuclease to efficiently correct liver metabolic diseases","volume":"4","author":"De Caneva","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtm.2023.101161_bib34","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.15252\/emmm.201707601","article-title":"Promoterless gene targeting without nucleases rescues lethality of a Crigler-Najjar syndrome mouse model","volume":"9","author":"Porro","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtm.2023.101161_bib35","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1096\/fj.11-195461","article-title":"Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer","volume":"26","author":"Bortolussi","year":"2012","journal-title":"Faseb. J."},{"key":"10.1016\/j.omtm.2023.101161_bib36","first-page":"1057","article-title":"Age-dependent pattern of cerebellar susceptibility to bilirubin neurotoxicity in\u00a0vivo in mice","volume":"7","author":"Bortolussi","year":"2014","journal-title":"Disease models\u00a0& mechanisms"},{"key":"10.1016\/j.omtm.2023.101161_bib37","doi-asserted-by":"crossref","first-page":"e104816","DOI":"10.1371\/journal.pone.0104816","article-title":"Generation of Ugt1-deficient murine liver cell lines using TALEN technology","volume":"9","author":"Porro","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2023.101161_bib38","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJM199805143382004","article-title":"Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation","volume":"338","author":"Fox","year":"1998","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2023.101161_bib39","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/s41587-022-01240-2","article-title":"Fludarabine increases nuclease-free AAV- and CRISPR\/Cas9-mediated homologous recombination in mice","volume":"40","author":"Tsuji","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2023.101161_bib40","doi-asserted-by":"crossref","first-page":"10548","DOI":"10.1038\/ncomms10548","article-title":"RS-1 enhances CRISPR\/Cas9- and TALEN-mediated knock-in efficiency","volume":"7","author":"Song","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2023.101161_bib41","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.omtm.2020.07.005","article-title":"Induction of ER Stress by an AAV5 BDD FVIII Construct Is Dependent on the Strength of the Hepatic-Specific Promoter","volume":"18","author":"Fong","year":"2020","journal-title":"Molecular Therapy - Methods\u00a0& Clinical Development"},{"key":"10.1016\/j.omtm.2023.101161_bib42","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.ymthe.2017.09.020","article-title":"Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of alpha-1 Antitrypsin Deficiency","volume":"25","author":"Borel","year":"2017","journal-title":"Mol. Ther. : the journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.omtm.2023.101161_bib43","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.ymthe.2020.12.027","article-title":"Correction of metabolic abnormalities in a mouse model of glycogen storage disease type Ia by CRISPR\/Cas9-based gene editing","volume":"29","author":"Arnaoutova","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.101161_bib44","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nbt.3469","article-title":"A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice","volume":"34","author":"Yang","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2023.101161_bib45","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1113\/EP086043","article-title":"Examination of CRISPR\/Cas9 design tools and the effect of target site accessibility on Cas9 activity","volume":"103","author":"Lee","year":"2018","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.omtm.2023.101161_bib46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1146\/annurev-genet-051710-150955","article-title":"Regulation of Homologous Recombination in Eukaryotes","volume":"44","author":"Heyer","year":"2010","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.omtm.2023.101161_bib47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.omtm.2018.12.011","article-title":"Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome","volume":"12","author":"Collaud","year":"2019","journal-title":"Molecular therapy Methods\u00a0& clinical development"},{"key":"10.1016\/j.omtm.2023.101161_bib48","series-title":"FastQC: A Quality Control Tool for High Throughput Sequence Data","author":"Andrews","year":"2010"},{"key":"10.1016\/j.omtm.2023.101161_bib49","first-page":"10","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnetjournal"},{"key":"10.1016\/j.omtm.2023.101161_bib50","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows\u2013Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtm.2023.101161_bib51","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"GigaScience"},{"key":"10.1016\/j.omtm.2023.101161_bib52","doi-asserted-by":"crossref","first-page":"11189","DOI":"10.1093\/nar\/gks918","article-title":"LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets","volume":"40","author":"Wilm","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2023.101161_bib53","article-title":"ideal: An R\/bioconductor package for interactive differential expression analysis","author":"Marini","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtm.2023.101161_bib54","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1158\/0008-5472.CAN-17-0337","article-title":"Variant Review with the Integrative Genomics Viewer","volume":"77","author":"Robinson","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtm.2023.101161_bib55","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nbt.3628","article-title":"CrispRVariants charts the mutation spectrum of genome engineering experiments","volume":"34","author":"Lindsay","year":"2016","journal-title":"Nat. Biotechnol."}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050123002000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050123002000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T15:22:13Z","timestamp":1762615333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050123002000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":55,"alternative-id":["S2329050123002000"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2023.101161","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR-Cas9-mediated somatic correction of a one-base deletion in the Ugt1a gene ameliorates hyperbilirubinemia in Crigler-Najjar syndrome mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2023.101161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"101161"}}